MSFT
Microsoft Corporation
MSFT has the edge over SRAD overall, supported by stronger valuation and lower modeled downside.
SRAD
Sportradar Group AG
SRAD's outlook is improving, though it still trails on the overall score.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
SRAD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
SRAD's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT has the edge over SRAD in the historical PE scenario, which offers more potential upside but is not a forecast.
SRAD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 61x | $3.69 | -71% |
| Fair | 113x | $6.76 | -48% |
| Expensive | 209x | $12.53 | -2.9% |
| Current | 231x | $12.91 | — |
Historical ranges are pointers, not guarantees.
SRAD's PE is 231x, but its earnings don't support one, so it isn't a reliable read right now.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
SRAD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
SRAD has the edge over MSFT on the outlook, with more favorable profitability expectations.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over SRAD on earnings, with more consistent year-over-year improvement.
SRAD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.06 | -84% |
| Q1 2026 | $0.24 | +14% |
| Q4 2025 | $0.34 | +183% |
| Q3 2025 | $0.32 | +52% |
| Q2 2025 | $0.38 | +375% |
| Q1 2025 | $0.21 | +133% |
| Q4 2024 | $0.12 | +9.1% |
| Q3 2024 | $0.21 | +$0.30 |
SRAD's earnings per share have fallen from their peak: $0.06 over the past year, against $0.38 in mid-2025.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT's revenue has grown year over year every quarter since late 2020: $92.3B last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over SRAD on profitability, with a higher operating margin.
SRAD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $426.7M | +21% |
| Q1 2026 | $391.3M | +13% |
| Q4 2025 | $406M | +19% |
| Q3 2025 | $324.4M | +14% |
| Q2 2025 | $353M | +14% |
| Q1 2025 | $345.7M | +17% |
| Q4 2024 | $341.1M | +22% |
| Q3 2024 | $283.5M | +27% |
SRAD has the edge over MSFT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 10% | +1.5 points |
| Q1 2026 | 7.3% | -0.1 points |
| Q4 2025 | 6.1% | -5.6 points |
| Q3 2025 | 16% | +1.1 points |
| Q2 2025 | 8.8% | -0.8 points |
| Q1 2025 | 7.4% | -5.1 points |
| Q4 2024 | 12% | +7 points |
| Q3 2024 | 15% | +15 points |
SRAD's operating margin was 10% last quarter, up 1.5 points from the same quarter a year ago.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
SRAD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $127.2M | +112% |
| Q1 2026 | $51.1M | +36% |
| Q4 2025 | $21.8M | +$24.3M |
| Q3 2025 | $126.7M | +78% |
| Q2 2025 | $60.1M | -12% |
| Q1 2025 | $37.7M | +1626% |
| Q4 2024 | -$2.5M | -185% |
| Q3 2024 | $71M | +178% |
SRAD has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has 7.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
SRAD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -4.2M shares |
| 1 year | -8.3% | -26.5M shares |
| 3 years | -5.3% | -16.5M shares |
| 5 years | -0.8% | -2.3M shares |
| Available history | -0.8% | -2.4M shares |
SRAD has the edge over MSFT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $141.3M |
| Q1 2026 | $101.6M |
| Q4 2025 | $26.7M |
| Q3 2025 | $2.2M |
| Q2 2025 | $69.5M |
| Q1 2025 | $18.5M |
| Q4 2024 | $9.9M |
| Q3 2024 | $8.7M |
SRAD spent $272M buying back its own shares over the past year, up 155% from the year before.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT's net debt is less than a year of its operating earnings (EBITDA).
SRAD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.5x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
| Q3 2024 | -0.8x | Net Cash |
SRAD has the edge over MSFT on leverage, with a lower net debt burden relative to earnings.
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
SRAD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.1 | Neutral |
| Stochastic | 38.9 | Neutral |
SRAD's weekly RSI is 45 (neutral) and its Stochastic is 39 (neutral).
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT has the edge over SRAD on valuation relative to its sector.
SRAD PE vs Technology Sector
| Metric | SRAD | Sector median | Relative |
|---|---|---|---|
| PE | 231x | 28x | 728% above |
| PE % | 87 | 45 | 42 pts above |
SRAD is trading at 231x earnings, a 728% premium to the Technology sector's median of 28x, though its earnings don't support one.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT has the edge over SRAD on trend strength, trading above more of its moving averages.
SRAD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.5 | 3.4% above |
| 20 week MA | $13.2 | 2.3% below |
| 50 week MA | $15.7 | 18% below |
| 100 week MA | $20.1 | 36% below |
| 200 week MA | $15.9 | 19% below |
SRAD has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 19% below its 200-week average.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has the edge over SRAD on returns for 2026, with the stronger performance.
SRAD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $27.0 | $18.6 | -31% |
| 2022 | $18.6 | $9.44 | -49% |
| 2023 | $9.44 | $11.1 | +17% |
| 2024 | $11.1 | $17.4 | +58% |
| 2025 | $17.4 | $23.1 | +33% |
| 2026 YTD | $23.1 | $12.9 | -44% |
SRAD is down 44% so far in 2026, after finishing higher in three of the previous five years.